Professional Documents
Culture Documents
HISTORY
Robert Grave, an Irish physician, first provided one of the earliest comprehensive clinical
descriptions of the disease. Although Graves did not discover the underlying cause of the
disease, he made significant contributions by describing the clinical features and symptoms
associated with it. His work, published in the early 19th century, laid the foundation for
understanding and diagnosing this thyroid disorder.
Caleb Hillier Parry, a British physician who lived in the late 18th and early 19th centuries,
also made notable contributions to the understanding of this disease. It wasn't until the
20th century that the autoimmune nature of Graves' disease began to be understood
PREVALENCE
Graves’ disease is the most common cause of hyperthyroidism accounting for 60% to 80% of
hyperthyroid cases
Graves' disease affects about 1 in 200 people. The disease occurs more often in women than in men, which
may be related to hormonal factors.
CAUSES
Hyperthyroidism
Genetic Predisposition:
Environmental Triggers:
While genetics may make a person more susceptible, environmental factors can
trigger the autoimmune response. These triggers may include viral or bacterial
infections, exposure to certain medications, physical or emotional stress, or other
environmental factors that are not fully understood.
Immune System Dysfunction:
The constant stimulation of the thyroid gland by these antibodies leads to the
overproduction of thyroid hormones, causing hyperthyroidism. This excess of thyroid
hormones affects various body systems and leads to the characteristic symptoms of
Graves' disease, such as rapid heart rate, weight loss, and heat intolerance.
Iodine Intake:
Excessive iodine intake, whether through diet or medication, can exacerbate thyroid
dysfunction in people with Graves' disease. Iodine is a key component of thyroid
hormones, and high levels of iodine can stimulate the thyroid gland.
Infection:
Some infections, particularly viral infections like Epstein-Barr virus or adenovirus,
have been suggested as potential triggers for autoimmune thyroid diseases,
including Graves' disease. These infections may contribute to the immune system's
misrecognition of the thyroid as a target.
SYMPTOMS
It can manifest with a wide range of symptoms, which can vary in severity from person to
person. Here are some common symptoms associated with Graves' disease:
Weight Loss:
Despite an increased appetite, individuals with Graves' disease often lose weight
unintentionally.
Heat Intolerance:
People with Graves' disease tend to be overly sensitive to heat and may sweat excessively.
They may feel warm or hot even in normal temperature environments.
Tremors:
Fine trembling of the hands and fingers (tremors) can be a noticeable symptom.
Fatigue: Paradoxically, patients may feel tired and weak despite the excess energy
expenditure due to hyperactivity.
Muscle Weakness:
Weakness and muscle fatigue are common, and individuals may have difficulty with tasks
that require muscle strength.
Goitre:
The thyroid gland can become visibly enlarged, causing a swelling in the neck known as a
goitre. This can sometimes cause discomfort or difficulty swallowing or breathing.
Skin Changes:
In some cases, the skin on the shins may become thickened and reddish in appearance, a
condition known as pretibial myxoedema.
Menstrual Irregularities:
Women with Graves' disease may experience changes in their menstrual cycle, including
irregular periods.
Hair Changes:
Hair may become fine and brittle, and some individuals may experience hair loss.
Emotional Disturbances:
Anxiety and depression can be associated with Graves' disease, partly due to the effects of
excessive thyroid hormones on mood.
TESTING
The following are some of the common tests and procedures used to confirm the
diagnosis of Graves' disease:
Antibody Tests:
Thyroid Stimulating Immunoglobulins (TSI) Test:
This blood test detects the presence of TSI, antibodies that stimulate the thyroid
gland to produce excessive amounts of thyroid hormones. TSI is often elevated in
Graves' disease and is a specific marker for the condition.
PATHALOGY
- The thyroid gland is symmetrically enlarged due to diffuse hypertrophy and
hyperplasia of thyroid follicular epithelial cells